Gaucher Type 1 (Ashkenazi) disease: a new method for heterozygote detection using a novel fluorescent natural substrate
- 1 September 1982
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 124 (1) , 123-135
- https://doi.org/10.1016/0009-8981(82)90326-6
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- An improved fluorometric leukocyte β-glucosidase assay for Gaucher's diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1981
- A modified method for the identification of heterozygotes for Gaucher's disease using differential thermal inactivationClinical Genetics, 1980
- Comparison of various β-glucosidase assays used to diagnose gaucher's diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1980
- Purification and properties of delta-aminolevulinate dehydrase from human erythrocytes.Journal of Biological Chemistry, 1979
- The assay of sphingolipid hydrolases in white blood cells with labelled natural substratesClinica Chimica Acta; International Journal of Clinical Chemistry, 1979
- Inborn errors of lysosomal catabolism—principles of heterozygote detectionAmerican Journal of Medical Genetics, 1979
- Synthetic substrate ß‐glucosidase activity in leukocytes: A reproducible method for the identification of patients and carriers of Gaucher's diseaseClinical Genetics, 1978
- Tay-sachs disease: An improved, fully-automated method for heterozygote identification by tear β-hexosaminidase assayClinica Chimica Acta; International Journal of Clinical Chemistry, 1977
- Ficoll-isopaque gradients for the determination of density distributions of human blood lymphocytes and other reticulo-endothelial cellsExperimental Cell Research, 1974
- N-Hexyl-0-glucosyl sphingosine, an inhibitor of glucosyl ceramide, β-glucosidaseJournal of Lipid Research, 1973